Press Releases

DURHAM, NC, and LIEGE, BELGIUM - August 26, 2010 - OncoMethylome Sciences (Euronext Brussels: ONCOB, Euronext Amsterdam: ONCOA), a leading molecular diagnostics company, announced today its 2010 half-year results and its new strategy.   Highlights   -     ...

Read More...

Madison, Wis. and Liege, Belgium, July 27, 2010 - 7:30 EDT - Exact Sciences Corp. (Nasdaq: EXAS) and OncoMethylome Sciences S.A. (Euronext Brussels: ONCOB) today announced that they have entered into a license agreement under which Exact Sciences has obtained exclusive, worldwide rights to up...

Read More...

Durham (NC, USA) and Liege (Belgium) - June 22, 2010, 18:00 CET - OncoMethylome Sciences SA (Euronext Brussels: ONCOB, Euronext Amsterdam: ONCOA) reports that as of June 14, 2010, ING Investment Management Luxembourg SA's shareholding is 4.95% of the total 13,185,614 outstanding shares of the...

Read More...

DURHAM, NC, and LIEGE, BELGIUM - May 31, 2010, 8:00 CET - OncoMethylome Sciences SA (Euronext Brussels: ONCOB, Euronext Amsterdam: ONCOA), a leading molecular diagnostics company, today announced that its Annual General Shareholders' Meeting (AGM) held on 28 May, 2010, approved the appointment of...

Read More...

DURHAM, NC, and LIEGE, BELGIUM - May 27, 2010,10:00 CET - OncoMethylome Sciences (Euronext Brussels: ONCOB; Euronext Amsterdam: ONCOA), a leading molecular diagnostics company, announced today that its Belgium based clinical diagnostics service laboratory has received the important ISO 9001:2008...

Read More...

Durham (NC, USA) and Liege (Belgium) - May 12, 2010, 18:00 CET - OncoMethylome Sciences SA (Euronext Brussels: ONCOB, Euronext Amsterdam: ONCOA) reports that it received a transparency statement which shows that on May 6, 2010, Drs. Herman Spolders reduced his shareholding in the company from 3.28...

Read More...

DURHAM, NC, and LIEGE, BELGIUM - May 6, 2010, 8:00 CET - OncoMethylome Sciences (Euronext Brussels: ONCOB; Euronext Amsterdam: ONCOA), a leading molecular diagnostics company in the field of cancer and pharmacogenomics, today issued its Q1 2010 business update, providing an overview of financial...

Read More...

* { font-family: Arial, Verdana, Helvetica; font-size: 13px;} td { padding: 3px; } }DURHAM, NC, and LIEGE, BELGIUM - May 3, 2010, 8:00 CET - OncoMethylome Sciences (Euronext Brussels: ONCOB; Euronext Amsterdam: ONCOA), a leading molecular diagnostics company, presented an update on its blood-based...

Read More...

Liege (Belgium) - April 12, 2010, 8:00 CET - OncoMethylome Sciences SA announced today that its board of directors has named Dr. Jan Groen to serve as the company's chief executive officer.  The company also reports that all agenda items for the Extraordinary General Shareholders' meeting held...

Read More...

Liège (Belgium) - March 11, 2010, 7:00 AM CET - OncoMethylome Sciences SA publishes its financial results for the period ended December 31, 2009.   2009 operational highlights:   Starting at the end of 2009, OncoMethylome focused its R&D efforts on four core areas: colorectal cancer...

Read More...

Pages